Videos

In this recent interview, Johannes Schoen, Boehringer Ingelheim speaks to Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and beyond" roundtable. Schoen discusses the outcomes of the roundtable and shares best practices for preparing for the Falsified Medicines Directive. view now

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. view now

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. view now

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. view now

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. view now

Meet a couple of Valea’s skilled and creative consultants and let them guide you through our offer, acomplete range of IP services. Valea’s team is made of consultants specialising in European patents, trademarks and design, as well as lawyers with specialist knowledge, considerable experience and expertise within all technical areasand legal issues related thereto. Our knowledge is combined with an in-depth understanding of the commercial value of intangible assets to our clients. view now

"Wherever you sit in the world as a regulator, most of the clinical trials you receive in marketing applications, most of the manufacturing that takes place for products is taking place in territories outside of the juristic ion of your regulatory system," said Fergus Sweeney, Head of Compliance & Inspection Patient Health Protection, European Medicines Agency (EMA). view now

Dr. Hans-Georg Eichler, Senior Medical Officer for the European Medicines Agency, talks about the Agency's growth, starting a common language between payers and regulators and the EMA's top priorities over the next few years. view now

The EMA's Sabine Brosch, speaks about collecting adverse drug reaction data worldwide, the importance of setting international standards for pharmacovigilance and collaborating to address global issues. Brosch also discusses how the EMA is working to improve pharmacovigilance, the impact of new legislation and social media and miscommunication. view now

Harry Rotgans, Head of investigation, Netherlands Health Care Inspectorate discusses insights into inspection and enforcement and optimisation of supply chain partners and governments working together view now

Chih-Hwa Wallace Lin, Senior Researcher, Director, Division of Resource Development, Center for Drug Evaluation (CDE) Tawian, speaks to Pharma IQ about streamlining the clinical trial process and reducing approval time. view now